DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Piribedil is an investigational drug.
There have been 5 clinical trials for Piribedil. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2010.
The most common disease conditions in clinical trials are Parkinson Disease, Tinnitus, and [disabled in preview]. The leading clinical trial sponsors are Desitin Arzneimittel GmbH, Faculdade de Medicina de Valenca, and FGK Clinical Research GmbH.
Recent Clinical Trials for Piribedil
|Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists||FGK Clinical Research GmbH||Phase 3|
|Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists||Desitin Arzneimittel GmbH||Phase 3|
|PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy||Desitin Arzneimittel GmbH||N/A|